Supplementary Table 3 from Phase IB Dose Escalation and Expansion Study of AKT Inhibitor Afuresertib with Carboplatin and Paclitaxel in Recurrent Platinum-resistant Ovarian Cancer Article Swipe

View

Sarah P. Blagden , Anne Hamilton , Linda Mileshkin , Shirley Wong , Agnieszka Michael , Marcia Hall , Jeffrey C. Goh , Alla S. Lisyanskaya , Michelle DeSilvio , Eleni Frangou , Euan A. Stronach , Prashanth Gopalakrishna , Tarek Meniawy , Hani Gabra ·

YOU? · · 2023 · Open Access · · DOI: https://doi.org/10.1158/1078-0432.22471170

Adverse events

Related Topics

Concepts

Carboplatin Paclitaxel Ovarian cancer Oncology Platinum Medicine Internal medicine Cancer Cisplatin Chemistry Chemotherapy Catalysis Biochemistry

Metadata

Type: supplementary-materials
Language: en
Landing Page: https://doi.org/10.1158/1078-0432.22471170
OA Status: gold
Related Works: 10
OpenAlex ID: https://openalex.org/W4361887385

All OpenAlex metadata

Raw OpenAlex JSON

OpenAlex ID: https://openalex.org/W4361887385

Canonical identifier for this work in OpenAlex
DOI: https://doi.org/10.1158/1078-0432.22471170

Digital Object Identifier
Title: Supplementary Table 3 from Phase IB Dose Escalation and Expansion Study of AKT Inhibitor Afuresertib with Carboplatin and Paclitaxel in Recurrent Platinum-resistant Ovarian Cancer

Work title
Type: supplementary-materials

OpenAlex work type
Language: en

Primary language
Publication year: 2023

Year of publication
Publication date: 2023-03-31

Full publication date if available
Authors: Sarah P. Blagden, Anne Hamilton, Linda Mileshkin, Shirley Wong, Agnieszka Michael, Marcia Hall, Jeffrey C. Goh, Alla S. Lisyanskaya, Michelle DeSilvio, Eleni Frangou, Euan A. Stronach, Prashanth Gopalakrishna, Tarek Meniawy, Hani Gabra

List of authors in order
Landing page: https://doi.org/10.1158/1078-0432.22471170

Publisher landing page
Open access: Yes

Whether a free full text is available
OA status: gold

Open access status per OpenAlex
OA URL: https://doi.org/10.1158/1078-0432.22471170

Direct OA link when available
Concepts: Carboplatin, Paclitaxel, Ovarian cancer, Oncology, Platinum, Medicine, Internal medicine, Cancer, Cisplatin, Chemistry, Chemotherapy, Catalysis, Biochemistry

Top concepts (fields/topics) attached by OpenAlex
Cited by: 0

Total citation count in OpenAlex
Related works (count): 10

Other works algorithmically related by OpenAlex

Full payload

id	https://openalex.org/W4361887385
doi	https://doi.org/10.1158/1078-0432.22471170
ids.doi	https://doi.org/10.1158/1078-0432.22471170
ids.openalex	https://openalex.org/W4361887385
fwci
type	supplementary-materials
title	Supplementary Table 3 from Phase IB Dose Escalation and Expansion Study of AKT Inhibitor Afuresertib with Carboplatin and Paclitaxel in Recurrent Platinum-resistant Ovarian Cancer
biblio.issue
biblio.volume
biblio.last_page
biblio.first_page
topics[0].id	https://openalex.org/T10550
topics[0].field.id	https://openalex.org/fields/27
topics[0].field.display_name	Medicine
topics[0].score	0.9607999920845032
topics[0].domain.id	https://openalex.org/domains/4
topics[0].domain.display_name	Health Sciences
topics[0].subfield.id	https://openalex.org/subfields/2743
topics[0].subfield.display_name	Reproductive Medicine
topics[0].display_name	Ovarian cancer diagnosis and treatment
is_xpac	False
apc_list
apc_paid
concepts[0].id	https://openalex.org/C2781451048
concepts[0].level	4
concepts[0].score	0.8869463205337524
concepts[0].wikidata	https://www.wikidata.org/wiki/Q415588
concepts[0].display_name	Carboplatin
concepts[1].id	https://openalex.org/C2777292972
concepts[1].level	3
concepts[1].score	0.7778578400611877
concepts[1].wikidata	https://www.wikidata.org/wiki/Q423762
concepts[1].display_name	Paclitaxel
concepts[2].id	https://openalex.org/C2780427987
concepts[2].level	3
concepts[2].score	0.5923271775245667
concepts[2].wikidata	https://www.wikidata.org/wiki/Q172341
concepts[2].display_name	Ovarian cancer
concepts[3].id	https://openalex.org/C143998085
concepts[3].level	1
concepts[3].score	0.5615663528442383
concepts[3].wikidata	https://www.wikidata.org/wiki/Q162555
concepts[3].display_name	Oncology
concepts[4].id	https://openalex.org/C518104683
concepts[4].level	3
concepts[4].score	0.5444409251213074
concepts[4].wikidata	https://www.wikidata.org/wiki/Q880
concepts[4].display_name	Platinum
concepts[5].id	https://openalex.org/C71924100
concepts[5].level	0
concepts[5].score	0.4762677848339081
concepts[5].wikidata	https://www.wikidata.org/wiki/Q11190
concepts[5].display_name	Medicine
concepts[6].id	https://openalex.org/C126322002
concepts[6].level	1
concepts[6].score	0.39471009373664856
concepts[6].wikidata	https://www.wikidata.org/wiki/Q11180
concepts[6].display_name	Internal medicine
concepts[7].id	https://openalex.org/C121608353
concepts[7].level	2
concepts[7].score	0.2468324899673462
concepts[7].wikidata	https://www.wikidata.org/wiki/Q12078
concepts[7].display_name	Cancer
concepts[8].id	https://openalex.org/C2778239845
concepts[8].level	3
concepts[8].score	0.18500679731369019
concepts[8].wikidata	https://www.wikidata.org/wiki/Q412415
concepts[8].display_name	Cisplatin
concepts[9].id	https://openalex.org/C185592680
concepts[9].level	0
concepts[9].score	0.16891533136367798
concepts[9].wikidata	https://www.wikidata.org/wiki/Q2329
concepts[9].display_name	Chemistry
concepts[10].id	https://openalex.org/C2776694085
concepts[10].level	2
concepts[10].score	0.16603884100914001
concepts[10].wikidata	https://www.wikidata.org/wiki/Q974135
concepts[10].display_name	Chemotherapy
concepts[11].id	https://openalex.org/C161790260
concepts[11].level	2
concepts[11].score	0.0
concepts[11].wikidata	https://www.wikidata.org/wiki/Q82264
concepts[11].display_name	Catalysis
concepts[12].id	https://openalex.org/C55493867
concepts[12].level	1
concepts[12].score	0.0
concepts[12].wikidata	https://www.wikidata.org/wiki/Q7094
concepts[12].display_name	Biochemistry
keywords[0].id	https://openalex.org/keywords/carboplatin
keywords[0].score	0.8869463205337524
keywords[0].display_name	Carboplatin
keywords[1].id	https://openalex.org/keywords/paclitaxel
keywords[1].score	0.7778578400611877
keywords[1].display_name	Paclitaxel
keywords[2].id	https://openalex.org/keywords/ovarian-cancer
keywords[2].score	0.5923271775245667
keywords[2].display_name	Ovarian cancer
keywords[3].id	https://openalex.org/keywords/oncology
keywords[3].score	0.5615663528442383
keywords[3].display_name	Oncology
keywords[4].id	https://openalex.org/keywords/platinum
keywords[4].score	0.5444409251213074
keywords[4].display_name	Platinum
keywords[5].id	https://openalex.org/keywords/medicine
keywords[5].score	0.4762677848339081
keywords[5].display_name	Medicine
keywords[6].id	https://openalex.org/keywords/internal-medicine
keywords[6].score	0.39471009373664856
keywords[6].display_name	Internal medicine
keywords[7].id	https://openalex.org/keywords/cancer
keywords[7].score	0.2468324899673462
keywords[7].display_name	Cancer
keywords[8].id	https://openalex.org/keywords/cisplatin
keywords[8].score	0.18500679731369019
keywords[8].display_name	Cisplatin
keywords[9].id	https://openalex.org/keywords/chemistry
keywords[9].score	0.16891533136367798
keywords[9].display_name	Chemistry
keywords[10].id	https://openalex.org/keywords/chemotherapy
keywords[10].score	0.16603884100914001
keywords[10].display_name	Chemotherapy
language	en
locations[0].id	doi:10.1158/1078-0432.22471170
locations[0].is_oa	True
locations[0].source
locations[0].license	cc-by
locations[0].pdf_url
locations[0].version	acceptedVersion
locations[0].raw_type	posted-content
locations[0].license_id	https://openalex.org/licenses/cc-by
locations[0].is_accepted	True
locations[0].is_published	False
locations[0].raw_source_name
locations[0].landing_page_url	https://doi.org/10.1158/1078-0432.22471170
indexed_in	crossref
authorships[0].author.id	https://openalex.org/A5068550336
authorships[0].author.orcid	https://orcid.org/0000-0001-8783-3491
authorships[0].author.display_name	Sarah P. Blagden
authorships[0].author_position	first
authorships[0].raw_author_name	Sarah P. Blagden
authorships[0].is_corresponding	False
authorships[1].author.id	https://openalex.org/A5012143202
authorships[1].author.orcid	https://orcid.org/0000-0003-0368-9838
authorships[1].author.display_name	Anne Hamilton
authorships[1].author_position	middle
authorships[1].raw_author_name	Anne L. Hamilton
authorships[1].is_corresponding	False
authorships[2].author.id	https://openalex.org/A5063000325
authorships[2].author.orcid	https://orcid.org/0000-0001-6826-6014
authorships[2].author.display_name	Linda Mileshkin
authorships[2].author_position	middle
authorships[2].raw_author_name	Linda Mileshkin
authorships[2].is_corresponding	False
authorships[3].author.id	https://openalex.org/A5011946923
authorships[3].author.orcid	https://orcid.org/0000-0003-3810-6495
authorships[3].author.display_name	Shirley Wong
authorships[3].author_position	middle
authorships[3].raw_author_name	Shirley Wong
authorships[3].is_corresponding	False
authorships[4].author.id	https://openalex.org/A5081884947
authorships[4].author.orcid	https://orcid.org/0000-0002-7262-6227
authorships[4].author.display_name	Agnieszka Michael
authorships[4].author_position	middle
authorships[4].raw_author_name	Agnieszka Michael
authorships[4].is_corresponding	False
authorships[5].author.id	https://openalex.org/A5016742379
authorships[5].author.orcid	https://orcid.org/0000-0003-0039-5041
authorships[5].author.display_name	Marcia Hall
authorships[5].author_position	middle
authorships[5].raw_author_name	Marcia Hall
authorships[5].is_corresponding	False
authorships[6].author.id	https://openalex.org/A5102823616
authorships[6].author.orcid	https://orcid.org/0000-0002-1681-0484
authorships[6].author.display_name	Jeffrey C. Goh
authorships[6].author_position	middle
authorships[6].raw_author_name	Jeffrey C. Goh
authorships[6].is_corresponding	False
authorships[7].author.id	https://openalex.org/A5024415050
authorships[7].author.orcid
authorships[7].author.display_name	Alla S. Lisyanskaya
authorships[7].author_position	middle
authorships[7].raw_author_name	Alla S. Lisyanskaya
authorships[7].is_corresponding	False
authorships[8].author.id	https://openalex.org/A5016756915
authorships[8].author.orcid
authorships[8].author.display_name	Michelle DeSilvio
authorships[8].author_position	middle
authorships[8].raw_author_name	Michelle DeSilvio
authorships[8].is_corresponding	False
authorships[9].author.id	https://openalex.org/A5090081649
authorships[9].author.orcid	https://orcid.org/0000-0002-5978-292X
authorships[9].author.display_name	Eleni Frangou
authorships[9].author_position	middle
authorships[9].raw_author_name	Eleni Frangou
authorships[9].is_corresponding	False
authorships[10].author.id	https://openalex.org/A5075772884
authorships[10].author.orcid
authorships[10].author.display_name	Euan A. Stronach
authorships[10].author_position	middle
authorships[10].raw_author_name	Euan A. Stronach
authorships[10].is_corresponding	False
authorships[11].author.id	https://openalex.org/A5112904657
authorships[11].author.orcid
authorships[11].author.display_name	Prashanth Gopalakrishna
authorships[11].author_position	middle
authorships[11].raw_author_name	Prashanth Gopalakrishna
authorships[11].is_corresponding	False
authorships[12].author.id	https://openalex.org/A5073719611
authorships[12].author.orcid	https://orcid.org/0000-0002-1457-6137
authorships[12].author.display_name	Tarek Meniawy
authorships[12].author_position	middle
authorships[12].raw_author_name	Tarek M. Meniawy
authorships[12].is_corresponding	False
authorships[13].author.id	https://openalex.org/A5025321863
authorships[13].author.orcid	https://orcid.org/0000-0002-3322-4399
authorships[13].author.display_name	Hani Gabra
authorships[13].author_position	last
authorships[13].raw_author_name	Hani Gabra
authorships[13].is_corresponding	False
has_content.pdf	False
has_content.grobid_xml	False
is_paratext	False
open_access.is_oa	True
open_access.oa_url	https://doi.org/10.1158/1078-0432.22471170
open_access.oa_status	gold
open_access.any_repository_has_fulltext	False
created_date	2025-10-10T00:00:00
display_name	Supplementary Table 3 from Phase IB Dose Escalation and Expansion Study of AKT Inhibitor Afuresertib with Carboplatin and Paclitaxel in Recurrent Platinum-resistant Ovarian Cancer
has_fulltext	False
is_retracted	False
updated_date	2025-11-06T03:46:38.306776
primary_topic.id	https://openalex.org/T10550
primary_topic.field.id	https://openalex.org/fields/27
primary_topic.field.display_name	Medicine
primary_topic.score	0.9607999920845032
primary_topic.domain.id	https://openalex.org/domains/4
primary_topic.domain.display_name	Health Sciences
primary_topic.subfield.id	https://openalex.org/subfields/2743
primary_topic.subfield.display_name	Reproductive Medicine
primary_topic.display_name	Ovarian cancer diagnosis and treatment
related_works	https://openalex.org/W2131322929, https://openalex.org/W4244439098, https://openalex.org/W2417982295, https://openalex.org/W2329492928, https://openalex.org/W2003594160, https://openalex.org/W3143032809, https://openalex.org/W3093965993, https://openalex.org/W1224191223, https://openalex.org/W1981117703, https://openalex.org/W1987294960
cited_by_count	0
locations_count	1
best_oa_location.id	doi:10.1158/1078-0432.22471170
best_oa_location.is_oa	True
best_oa_location.source
best_oa_location.license	cc-by
best_oa_location.pdf_url
best_oa_location.version	acceptedVersion
best_oa_location.raw_type	posted-content
best_oa_location.license_id	https://openalex.org/licenses/cc-by
best_oa_location.is_accepted	True
best_oa_location.is_published	False
best_oa_location.raw_source_name
best_oa_location.landing_page_url	https://doi.org/10.1158/1078-0432.22471170
primary_location.id	doi:10.1158/1078-0432.22471170
primary_location.is_oa	True
primary_location.source
primary_location.license	cc-by
primary_location.pdf_url
primary_location.version	acceptedVersion
primary_location.raw_type	posted-content
primary_location.license_id	https://openalex.org/licenses/cc-by
primary_location.is_accepted	True
primary_location.is_published	False
primary_location.raw_source_name
primary_location.landing_page_url	https://doi.org/10.1158/1078-0432.22471170
publication_date	2023-03-31
publication_year	2023
referenced_works_count	0
abstract_inverted_index.<p>Adverse	0
abstract_inverted_index.events</p>	1
cited_by_percentile_year
countries_distinct_count	0
institutions_distinct_count	14
sustainable_development_goals[0].id	https://metadata.un.org/sdg/3
sustainable_development_goals[0].score	0.47999998927116394
sustainable_development_goals[0].display_name	Good health and well-being
citation_normalized_percentile.value	0.07857143
citation_normalized_percentile.is_in_top_1_percent	False
citation_normalized_percentile.is_in_top_10_percent	False